Meth Addiction Treatment in Cherry Hill, NJ
Methamphetamine use disorder is one of the most challenging substance addictions to treat — but recovery is absolutely possible with the right clinical approach. Hope Harbor Addiction Center in Cherry Hill provides evidence-based meth addiction treatment for South Jersey adults, including behavioral therapy, dual diagnosis care, and both inpatient and outpatient levels of care. Call us 24/7 at (732) 523-5239 for a confidential consultation.
Methamphetamine Use in New Jersey and the Mid-Atlantic Region
While New Jersey's opioid epidemic has dominated headlines, methamphetamine use has been rising steadily across the state and the broader Mid-Atlantic region. According to SAMHSA data, stimulant-related treatment admissions — including methamphetamine — have increased significantly over the past decade. Meth is increasingly detected in combination with fentanyl in the NJ drug supply, raising overdose risk even for people who believe they are using stimulants only.
Methamphetamine's powerful effect on the brain's dopamine reward system makes it highly addictive. A single use produces a surge of dopamine up to three times greater than natural reward stimuli — rapidly establishing reinforcement pathways that drive compulsive use. Over time, the brain's natural dopamine production diminishes, leaving people unable to feel pleasure without the drug.
Meth Withdrawal: The Crash and Beyond
Unlike opioid or alcohol withdrawal, methamphetamine withdrawal does not typically produce dramatic physical symptoms — but the psychological withdrawal is intense and prolonged:
- Phase 1 — The Crash (Days 1–3): Extreme fatigue, hypersomnia (sleeping 12–20 hours), increased appetite, and relatively diminished cravings. The body is in a state of exhaustion recovery.
- Phase 2 — Early Withdrawal (Days 4–14): Intense drug cravings emerge, along with severe depression, anhedonia, anxiety, irritability, and cognitive impairment. This is the most psychologically difficult phase and the highest relapse risk window.
- Phase 3 — Protracted Withdrawal (Weeks 3–12+): Mood instability, intermittent strong cravings, ongoing cognitive issues, and low-grade depression. Recovery of dopamine function is gradual and continues over months with sustained abstinence.
Medical supervision during the crash and early withdrawal phases provides safety monitoring, management of depression and suicidality risk (which can be elevated during meth withdrawal), and comfort support.
Behavioral Treatment: The Cornerstone of Meth Recovery
Because no FDA-approved medication exists for methamphetamine use disorder, behavioral treatment is the primary and most evidence-based intervention. Hope Harbor's meth treatment program uses:
- Contingency Management (CM): The most evidence-based behavioral intervention specifically for stimulant use disorders. Patients earn vouchers or small incentive rewards for drug-negative urine tests. CM leverages the brain's reward system — the same system damaged by meth — to reinforce abstinence during early recovery. The evidence base for CM in meth treatment is among the strongest in addiction medicine.
- Cognitive Behavioral Therapy (CBT): Helps patients identify triggers, thoughts, and emotional states that drive meth use, and develop concrete coping strategies. CBT skills are particularly valuable for managing the prolonged craving and anhedonia of post-acute meth withdrawal.
- Motivational Enhancement Therapy (MET): Addresses ambivalence about stopping — common with meth given the powerful short-term pleasure the drug produces.
- The Matrix Model: A structured outpatient treatment approach developed specifically for stimulant use disorders, incorporating CBT, family therapy, 12-step facilitation, and regular drug testing.
Dual Diagnosis: Meth and Co-Occurring Mental Health Conditions
Methamphetamine use disorder frequently co-occurs with depression, anxiety, PTSD, and — particularly — meth-induced psychosis. Understanding which mental health symptoms are substance-induced versus pre-existing is an important part of the clinical picture:
- Depression: Often the most prominent feature of meth withdrawal and early recovery. Dopamine system depletion produces profound anhedonia that can resemble major depressive disorder. This typically improves with sustained abstinence but may benefit from antidepressant treatment.
- Anxiety: Common in early recovery, often driven by withdrawal itself. Can persist as a co-occurring condition.
- Psychosis: Acute meth-induced psychosis during active use, or persistent psychotic symptoms in heavy long-term users. Requires careful psychiatric evaluation and management.
Hope Harbor's dual diagnosis treatment program includes psychiatric evaluation, medication management for co-occurring conditions, and integrated behavioral treatment — addressing both the meth use disorder and any co-occurring mental health conditions simultaneously.
Ready to Start Recovery? Our Cherry Hill Team is Available 24/7.
Free, confidential assessments. Insurance accepted. Same-day intake available.
Levels of Care for Meth Treatment at Hope Harbor
The right level of care depends on the severity of methamphetamine use, the presence of co-occurring conditions, and your home environment:
- Medical Detox: Medically supervised crash management, safety monitoring, and sleep/mood support. See our drug detox program.
- Inpatient/Residential: Recommended for severe meth use disorder, co-occurring psychosis or depression, or unstable living environments. Extended residential treatment (60–90 days) produces the best outcomes for methamphetamine. See our inpatient rehab program.
- Intensive Outpatient (IOP): For patients with stable housing and social support who can manage the early recovery period in the community. See our IOP in Cherry Hill.
Meth Addiction Treatment FAQs
Frequently Asked Questions
Currently, no medication is FDA-approved specifically for methamphetamine use disorder. Research is ongoing — bupropion (Wellbutrin) and naltrexone in combination have shown some benefit in clinical trials, and injectable naltrexone alone shows modest evidence. The most evidence-based treatment for meth use disorder remains behavioral: contingency management has the strongest research base of any intervention for stimulant use disorders, and cognitive behavioral therapy is the cornerstone of meth treatment.
Methamphetamine withdrawal is primarily psychological rather than physical. The most prominent symptoms are extreme fatigue and hypersomnia (sleeping 12–18+ hours), intense drug cravings, profound depression and anhedonia (inability to feel pleasure), irritability, anxiety, and cognitive impairment (difficulty concentrating, 'brain fog'). This crash phase typically peaks in the first 1–3 days and extends through the first 1–2 weeks, with mood and cognitive effects potentially persisting for months. Medical supervision helps manage the safety and comfort of the withdrawal period.
Heavy methamphetamine use causes measurable changes to brain structure and function — particularly to the dopamine system, which regulates reward, motivation, and movement. Neuroimaging studies show reduced dopamine transporter levels and structural changes in the prefrontal cortex and striatum. The encouraging news: many of these changes show significant recovery with extended abstinence. Studies show partial or full recovery of dopamine function after 12–14 months of abstinence in many users. This is why long-term, sustained treatment produces meaningfully better outcomes than short programs.
High doses of methamphetamine can cause acute psychosis — paranoia, auditory or visual hallucinations, and disorganized thinking that can closely resemble schizophrenia. Meth-induced psychosis typically resolves within days to a week after stopping use in most cases. However, some people experience psychotic symptoms that persist for months, and repeated meth use appears to increase vulnerability to future psychotic episodes. Dual diagnosis treatment that addresses both the meth use disorder and any persistent psychotic symptoms is essential.
Research on methamphetamine treatment outcomes consistently shows that longer treatment is associated with significantly better outcomes. While a 30-day program can initiate recovery, most treatment guidelines recommend 90 days or more for meth use disorder, particularly given the prolonged post-acute withdrawal symptoms (depression, cognitive impairment, cravings) that persist well beyond the initial withdrawal phase. Hope Harbor develops individualized treatment plans that account for the severity and duration of meth use.
Ready to Start Recovery? Our Cherry Hill Team is Available 24/7.
Free, confidential assessments. Insurance accepted. Same-day intake available.